Self-limited (familial) infantile epilepsy …

Parmpreet Dhillon MD

Epilepsy & Seizures

Updated 01.25.2024
Released 03.29.2001
Expires For CME 01.25.2027

Self-limited (familial) infantile epilepsy

Author: Parmpreet Dhillon MD

See Contributor Disclosures

Editor: Solomon L Moshé MD

Self-limited (familial) infantile epilepsy

In This Article

Quick Link

Introduction

Overview

Formerly called “benign infantile epilepsy,” self-limited infantile epilepsy is a syndrome characterized by the onset of seizures in the infantile period that spontaneously resolve with normal developmental progress. Self-limited familial infantile epilepsy and nonfamilial infantile epilepsy may be identical except for the presence of a family history.

Key points

	• Formerly called “benign” (familial) infantile seizures or epilepsy,” the new ILAE syndrome classification name is “self-limited (familial) infantile epilepsy” (SeLIE).
	• Seizure onset peaks at 6 months of age. Seizures may be frequent at onset but usually remit within 1 year from onset with normal developmental progress.
	• Patients with the most common pathogenic variant, PRRT2, may develop paroxysmal kinesigenic dyskinesia/dystonia.
	• Familial cases show autosomal dominant inheritance with incomplete penetrance.

Historical note and terminology

In 1963 Fukuyama described cases of epilepsy occurring in the first 2 years of life that were characterized by focal seizures, absence of etiologic factors, and good neurologic outcome (20). Later, Watanabe and colleagues reported on the localization and semiology of these seizures. Specifically, they described partial epilepsy of infancy with complex partial seizures and benign partial epilepsy with secondarily generalized seizures in infancy (58; 59; 57). Other groups documented prognosis (46), and presence or absence of familial occurrence (54; 55; 56).

Since the description of the original syndromes (familial and nonfamilial) and their categorization in the 1989 Classification of Epilepsies and Epileptic Syndromes of the International League Against Epilepsy (ILAE), other rarer related syndromes have emerged. These include “benign familial infantile seizures with choreoathetosis” (48) or paroxysmal dyskinesia (18), “benign familial neonatal-infantile seizures” (25; 24; 62), “benign familial infantile seizures with familial hemiplegic migraine” (49; 52; 35), “benign infantile seizures with mild gastroenteritis” (11), and “benign infantile focal seizures with midline spikes and wave during sleep” (19).

The terminology of these syndromes has evolved slightly over time. Vigevano and colleagues focused their attention on cases that exhibited a family history of convulsions with good neurologic outcome during infancy and autosomal dominant inheritance, suggesting the term "benign infantile familial convulsions” (54; 55; 56). In 2001, the ILAE Task Force on Classification and Terminology stated that the term "seizure" should be used preferentially over the term "convulsion" (17), a stance that has been supported by Berg and colleagues (01). Thereafter the syndromes were referred to as “benign familial infantile seizures” and “benign nonfamilial infantile seizures” (17), which are distinct syndromes with some overlapping features (33; 09). In the 2010 report of the ILAE Commission on Classification and Terminology (01), “benign infantile epilepsy” and “benign familial infantile epilepsy” have been identified and classified among the electroclinical syndromes of infancy.

In the 2021 proposed classification and definition of epilepsy syndromes in the neonate and infant, the ILAE replaced the term “benign” with “self-limited.”

Clinical manifestations

Presentation and course

Self-limited infantile epilepsy typically presents at the age of 3 to 20 months with a peak at 6 months. Epilepsies that present earlier (in the first week and first few months) would likely be classified as the distinct syndrome of self-limited neonatal and neonatal-infantile epilepsies.

Preceding gestational, birth, and neonatal history is typically normal with normal head size and neurologic examination. Preceding and subsequent to the epilepsy, psychomotor development is normal.

Seizures present as focal seizures with behavioral arrest, automatisms, head and eye version, and clonic movements. Focal clonic seizures may alternate from one side to the other and progress to a bilateral tonic-clonic seizure.

Seizures are usually brief, lasting less than 3 minutes; longer seizures can occur but are rare. Seizures can be frequent at onset. Some patients may present with a single seizure 2 weeks before the frequent seizures start.

The seizures are classically quite responsive to pharmacologic treatment. However, in untreated cases, there may be isolated or brief clusters of seizures that will persist if treatment is withheld, often through the second year of life. Irrespective of pharmacologic treatment, all seizures will typically remit within 1 year of onset (by the age of 2). A minority of individuals may have epilepsy persisting into later life.

In familial cases first and second-degree relatives endorse history of infantile seizures that resolved, often with an autosomal dominant inheritance pattern. Testing for etiologic factors, including metabolic and neuroimaging studies, are unrevealing. Patients with PRRT2 pathogenic variants may develop paroxysmal kinesigenic dyskinesia/dystonia beginning from childhood to adult life. This diagnosis may often be missed as the symptoms of a movement disorder may be brief and last only seconds. These symptoms are easily controlled with carbamazepine.

In the rarer subtypes, there is often an additional clinical feature or symptom that emerges after the resolution of the epilepsy and each syndrome is so named. For example, patients with self-limited familial infantile seizures with choreoathetosis will develop choreoathetotic movements in infancy or later in childhood. They occur at rest or during exertion/anxiety and are dystonic (48; 18). Patients with self-limited familial infantile seizures with familial hemiplegic migraine go on to develop hemiplegic migraine attacks (49; 52; 35).

Seizures are associated with gastroenteritis in self-limited infantile seizures with mild gastroenteritis (11) and there is an electrographic signature of midline or vertex spikes during sleep in self-limited infantile focal seizures with midline spikes and wave during sleep (19).

Prognosis and complications

Children with self-limited infantile seizures generally have normal psychomotor development and do not manifest other forms of epilepsy later in life. Seizures remit within 1 year of onset. The EEGs performed at follow-up remain normal.

Of note, up to 10% to 30% can have seizure recurrence later in life, with one study noting this in more children with more seizures and longer duration of epilepsy (36; 27).

Clinical vignette

The following is an example of a familial case reported by F Vigevano as well as by Giordano and colleagues (22).

A 3-months 21-days-old girl presented with a cluster of seizures characterized by fixed gaze, bilateral clonic jerks, and loss of consciousness that lasted 2 minutes.

On admission, a seizure was observed that was characterized by slow deviation of the head and eyes to the left and then to the right, loss of consciousness, oral automatisms, diffuse hypertonia, and bilateral clonic jerks. All laboratory testing (organic acids, lactate, pyruvate, ammonia in plasma, and urine) and neuroradiological examinations (CT head and MRI brain) were negative. EEG during wakefulness and sleep were normal.

At that time, neurologic examination and psychomotor development were normal, and no antiepileptic drug therapy was prescribed at the parent’s request. The patient continued to have three to four seizures per month from 5 to 7 months of age. Only a single seizure was reported from 7 to 11 months of age. At 1 year of age, the patient became seizure free. Neurologic examination and developmental trajectory remained normal.

There was a strong family history of convulsions during infancy, including 18 of 35 members of the mother’s family. In particular, the father and all but one of the mother’s siblings (four sisters and six brothers) presented with similar seizures. In all 18 members of the affected family, the clinical characteristics of the seizures were similar to those described in the proband. In all 18 members, seizure onset was at 3 to 4 months of age and remission was achieved at 9 to 10 months of age. All affected members experienced seizure clusters at onset and subsequently isolated seizures, with frequency similar to that of the proband. The proband’s grandmother considered this type of convulsion to be a characteristic trait of the family and as such none of the 18 subjects received antiepileptic drug treatment.

All 18 affected family members had normal psychomotor development and attended high school. None of them experienced febrile convulsions, nor did they develop epilepsy.

Biological basis

Etiology and pathogenesis

The etiologies of the self-limited familial infantile epilepsy syndromes are genetic. The self-limited nonfamilial epilepsy syndromes are less well understood, and their etiologies are likely multifactorial. Autosomal dominant transmission is seen in self-limited familial infantile seizures with high penetrance.

In the past several years it has been discovered that a large percentage of patients affected by self-limited familial infantile seizures have a mutation in the proline-rich transmembrane protein 2 (PRRT2) gene located on chromosome 16p12-q12 (10; 60; 45; 42). In 2012, the largest study performed so far in families with “pure” self-limited familial infantile seizures showed the occurrence of a mutation of PRRT2 in 83% of them (41). Additionally, a large Italian collaborative study confirmed PRRT2 mutations in most of the families, but with a slightly lower incidence than in the previous study (70%) (62). This mutation is not seen in families with self-limited familial neonatal seizures (23).

Previously the PRRT2 gene was implicated in paroxysmal kinesigenic dyskinesia (13) and in fact paroxysmal kinesigenic dyskinesia is observed later in life in some patients with self-limited familial infantile seizures with PRRT2 mutations (26; 37). This entity will be discussed below.

The product of the PRRT2 gene is a proline-rich protein whose precise function has not yet been elucidated. Its role seems related to synaptic function because it interacts, both in vitro and in vivo, with synaptosomal-associated protein 25 kDa (SNAP 25), a synaptic protein (43; 29; 51). SNAP 25 plays a relevant role in neurotransmitter exocytosis, vesicle docking, and fusion to the plasma membrane. Indeed, it has been shown in vitro that PRRT2 plays an important role in specific steps of neurotransmitter release (51). Further work must be done to elucidate (1) whether the mutations found so far are related to a loss of function and to what extent, and (2) why the epileptic syndromes associated with PRRT2 mutations have a limited time window of phenotypic expression, resolving without sequelae. It is worth noting here that the expression levels of CNS PRRT2 seem to vary during development, and apparently with a region-specific pattern (13; 26); this might be at least in part in line with the age-specific/self-limiting presentation of seizures, as well as with the phenotypic variability among patients. The mechanism by which this mutation is related to the occurrence of this brief, self-limited epilepsy syndrome is not well understood.

Interestingly, the PRRT2 sequence is highly preserved throughout phylogenesis (29), and this might help in understanding its precise role and function through experimental studies in rodents.

Other pathogenic mutations have been suggested. Zara and colleagues suspected involvement of KCNQ2, KCNQ3, and SCN2A and found that only approximately 10% of self-limited familial infantile seizures families had none of the three mutations (62). Subsequent linkage studies confirming these results have not yet been undertaken.

Self-limited familial infantile seizures and choreoathetosis. As discussed above, PRRT2 mutations are frequently found in patients with isolated self-limited familial infantile seizures; however, they also occur in patients with self-limited familial infantile seizures who later develop choreoathetosis or paroxysmal kinesigenic dyskinesias.

In 1997 Szepetowski and colleagues demonstrated linkage to this pericentromeric region of chromosome 16 in four French families with the syndrome of self-limited familial infantile seizures and choreoathetosis (48). This finding was later replicated by several other groups studying families of varying ethnicities (32; 47; 10). The mutation is present in up to 80% of families with self-limited familial infantile seizures with choreoathetosis (29; 26; 37) and seems to be inherited in an autosomal dominant manner.

Additionally, a mutation of the SCN8A gene has been described in families of patients affected by both paroxysmal dyskinesia and self-limited familial infantile seizures. Notably, these families did not have a coexisting PRRT2 mutation (21).

Self-limited familial neonatal-infantile seizures. In 2002 Heron and colleagues reported the presence of a mutation in the sodium channel subunit gene SCN2A in two families with seizure onset between 1 and 3 months of life, which was intermediate between neonatal and infantile forms. One of the families also had mutations in KCNQ2 and KCNQ3 (25). Later, the same group found mutations in the sodium channel gene SCN2A in six other families (02). The authors coined the term “benign familial neonatal-infantile seizures,” referring to their patients whose epilepsy onset was between day 2 of life and 7 months of life. In 2006, Striano and colleagues reported a novel heterozygous mutation c3003 T → A in the SCN2A gene in a family with three affected individuals over three generations (44). All subjects in this series experienced clusters of focal seizures with or without secondary generalization, onset between 4 and 12 months of life, and had been diagnosed with self-limited familial infantile seizures. This report provided new evidence that suggested self-limited familial neonatal-infantile seizures and self-limited familial infantile seizures may have some overlapping clinical and genetic characteristics. However, it could not be excluded that the family described by Striano and colleagues (44) was affected by self-limited familial neonatal-infantile seizures, as suggested by Herlenius and colleagues (24).

Self-limited familial infantile seizures with familial hemiplegic migraine. There is a subset of patients with self-limited familial infantile seizures who go on to experience hemiplegic migraine later in life, long after the resolution of the epilepsy. A mutation in ATP1A2 has been identified in some of these patients (49; 52). The loss of function mutation is hypothesized to lead to neuronal hyperexcitability and facilitate cortical spreading depression, which is a mechanism believed to be involved in both epilepsy and migraine.

Self-limited nonfamilial infantile seizures. The data on gene(s) involved in the sporadic cases are scarce. It has been observed that PRRT2 mutations do occur in some nonfamilial cases, as a de novo mutation (40; 42).

Self-limited infantile seizures with mild gastroenteritis. There are reports of sporadic cases of self-limited infantile convulsions associated with prolonged episodes of diarrhea caused by rotavirus infections (14). However, clear cause-effect relation is still to be demonstrated as other groups have found this entity to occur in infants with mild gastroenteritis that is rotavirus negative (11). Several large series of these patients have been described (15; 12). There has been some documentation of the lack of PRRT2 mutations in the few patients with convulsions with mild gastroenteritis assessed thus far (40; 28).

Self-limited focal epilepsy in infancy with midline spikes and waves during sleep. Capovilla and colleagues described a series of 12 patients who shared the clinical presentation of self-limited nonfamilial infantile seizures; however, they had interictal EEG abnormalities unlike the previously described cases. In all cases, characteristic spike and wave discharges were present over the vertex during sleep whereas the interictal EEG during wakefulness remained normal. On the basis of these uniform electroclinical features, the group proposed the creation of a new syndrome (06). The patients appear to have a self-limited outcome with normal psychomotor development and quick resolution of the epilepsy, and as such it has been suggested that they do not simply represent an early onset of other previously described epilepsy syndromes (07; 19).

Diagnostic workup

In the setting of an appropriate family history, diagnostic testing may be minimal if self-limited familial infantile seizures are suspected.

In the absence of such a history, diagnostic workup will often be directed at ruling out other causes of the seizures. This evaluation will begin with collecting historical information on prenatal, perinatal, or postnatal etiologic factors, data on psychomotor development, clinical condition prior to seizure onset, and family history when available. Normal neurologic examination must be confirmed.

Diagnostic testing may include blood and urine tests to exclude infectious or metabolic disorders (complete blood count, comprehensive metabolic panel, organic acids, lactate, pyruvate, ammonia, cultures of blood/urine/CSF as indicated). Video EEG is advisable to characterize the suspected episodes as seizures and document the interictal record, which will be normal in most cases. Although focal slowing may occur postictally, a structural brain abnormality should be considered if there is persistent focal slowing in one area (53). Diffuse, persistent slowing in the background would suggest a different syndrome. A variant with midline spikes during slow sleep has been described (03; 19).

The ictal recording is characterized by focal discharges, which is often onset in temporal or posterior head regions and may spread to both hemispheres (53). The seizure onset may vary from lobe to lobe or from hemisphere to hemisphere in different seizures in the same patient. However, the ictal pattern within the same seizure does not show a migrating pattern. This is consistent with the alternating semiology described by Vigevano and associates (55; 56). Subsequently, several groups have failed to demonstrate significant differences in region of onset or EEG characteristics between patients with familial and nonfamilial benign self-limited infantile seizures (33; 09).

Neuroimaging is normal.

A genetic etiology can be identified in up to 80% of cases, and PRRT2 is the gene most commonly implicated (05; 26). Other genes associated with this syndrome include SCN8A, SCN2A, KCNQ2, KCNQ3.

Exclusionary data would include the following (63):

• Age of onset younger than 1 month or older than 36 months
• Significant neurodevelopmental delay or neurocognitive regression
• Other seizure types aside from focal/focal to bilateral tonic clonic
• EEG findings of persistent focal or background slowing or hypsarrhythmia
• MRI lesion

References

01: Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010;51(4):676-85. PMID 20196795
02: Berkovic SF, Heron SE, Giordano L, et al. Benign familial neonatal-infantile seizures: characterization of a new sodium channelopathy. Ann Neurol 2004;55:550-7. PMID 15048894
03: Bureau M, Cokar O, Maton B, Genton P, Dravet C. Sleep-related, low voltage Rolandic and vertex spikes: an EEG marker of benignity in infancy-onset focal epilepsies. Epileptic Disord 2002;4:15-22. PMID 11967175
04: Callenbach PM, De Coo RF, Vein AA, et al. Benign familial infantile convulsions: a clinical study of seven Dutch families. Eur J Paediatr Neurol 2002;6:269-83. PMID 12374579
05: Camfield CS, Camfield PR, Gordon K, Wirrell E, Dooley JM. Incidence of epilepsy in childhood and adolescence: a population-based study in Nova Scotia from 1977 to 1985. Epilepsia 1996;37:19-23. PMID 8603618
06: Capovilla G, Beccaria F. Benign partial epilepsy in infancy and early childhood with vertex spikes and waves during sleep: a new epileptic form. Brain Dev 2000;22:93-9. PMID 10722959
07: Capovilla G, Beccaria F, Montagnini A. Benign focal epilepsy in infancy with vertex spikes and waves during sleep. Delineation of the syndrome and recalling as 'benign infantile focal epilepsy with midline spikes and waves during sleep (BIMSE). Brain Dev 2006;28(2):85-91. PMID 15967619
08: Capovilla G, Giordano L, Tiberti S, Valseriati D, Menegati E. Benign partial epilepsy in infancy with complex partial seizures (Watanabe's syndrome): 12 non-Japanese new cases. Brain Dev 1998;20:105-11. PMID 9545181
09: Caraballo RH, Cersósimo RO, Espeche A, Fejerman N. Benign familial and non-familial infantile seizures: a study of 64 patients. Epileptic Disord 2003;5:45-9. PMID 12773296
10: Caraballo R, Pavek S, Lemainque A, et al. Linkage of benign familial infantile convulsions to chromosome 16p12-q12 suggests allelism to the infantile convulsions and choreoathetosis syndrome. Am J Hum Genet 2001;68:788-94. PMID 11179027
11: Caraballo RH, Ganez L, De Los Santos C, Espeche A, Cersosimo R, Fejerman N. Benign infantile seizures with mild gastroenteritis: study of 22 patients. Seizure 2009;18(10):686-9. PMID 19828335
12: Castellazzi L, Principi N, Agostoni C, Esposito S. Benign convulsions in children with mild gastroenteritis. Eur J Paediatr Neurol 2016;20(5):690-5. PMID 27292317
13: Chen WJ, Lin Y, Xiong ZQ, et al. Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia. Nat Genet 2011;43(12):1252-5. PMID 22101681
14: Contino MF, Lebby T, Arcinue EL. Rotavirus gastrointestinal infection causing afebrile seizures in infancy and childhood. Am J Emerg Med 1994;12:94-5. PMID 8285986
15: Cusmai R, Jocic-Jakubi B, Cantonetti L, Japaridze N, Vigevano F. Convulsions associated with gastroenteritis in the spectrum of benign focal epilepsies in infancy: 30 cases including four cases with ictal EEG recording. Epileptic Disord 2010;12(4):255-61. PMID 21097391
16: Echenne B, Humbertclaude V, Rivier F, Malafosse A, Cheminal R. Benign infantile epilepsy with autosomal dominant inheritance. Brain Dev 1994;16:108-11. PMID 8048696
17: Engel Jr J. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001;42(6):796-803. PMID 11422340
18: Espeche A, Cersosimo R, Caraballo RH. Benign infantile seizures and paroxysmal dyskinesia: A well-defined familial syndrome. Seizure 2011;20(9):686-91. PMID 21764335
19: Flesler S, Sakr D, Cersósimo R, Caraballo R. Benign infantile focal epilepsy with midline spikes and waves during sleep: a new epileptic syndrome or a variant of benign focal epilepsy? Epileptic Disord 2010;12(3):205-11. PMID 20822975
20: Fukuyama Y. Borderland of epilepsy with special reference to febrile convulsions and so-called infantile convulsions. Seishing-Igaku (Clin Psychiatry) 1963;5:211-23.
21: Gardella E, Becker F, Møller RS, et al. Benign infantile seizures and paroxysmal dyskinesia caused by an SCN8A mutation. Ann Neurol 2016;79(3):428-36. PMID 26677014
22: Giordano L, Accorsi P, Valseriati D, et al. Benign infantile familial convulsions: natural history of a case and clinical characteristics of a large Italian family. Neuropediatrics 1999;30:99-101. PMID 10401694
23: Grinton BE, Heron SE, Pelekanos JT, et al. Familial neonatal seizures in 36 families: Clinical and genetic features correlate with outcome. Epilepsia 2015;56(7):1071-80. PMID 25982755
24: Herlenius E, Heron SE, Grinton BE, et al. SCN2A mutations and benign familial neonatal-infantile seizures: the phenotypic spectrum. Epilepsia 2007;48(6):1138-42. PMID 17386050
25: Heron SE, Crossland KM, Andermann E, et al. Sodium-channel defects in benign familial neonatal-infantile seizures. Lancet 2002;360:851-2. PMID 12243921
26: Heron SE, Grinton BE, Kivity S, et al. PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome. Am J Hum Genet 2012;90(1):152-60.** PMID 22243967
27: Innes EA, Marne FAL, Macintosh R, et al. Neurodevelopmental outcomes in a cohort of Australian families with self-limited familial epilepsy of neonatal/infantile onset. Seizure 2024;115:1-13. PMID 38160512
28: Ishii A, Yasumoto S, Ihara Y, et al. Genetic analysis of PRRT2 for benign infantile epilepsy, infantile convulsions with choreoathetosis syndrome, and benign convulsions with mild gastroenteritis. Brain Dev 2013;35(6):524-30. PMID 23073245
29: Lee HY, Huang Y, Bruneau N, et al. Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep 2012;1(1):2-12. PMID 22832103
30: Lee J, Kim YO, Lim BC, Lee J. PRRT2-positive self-limited infantile epilepsy: Initial seizure characteristics and response to sodium channel blockers. Epilepsia Open 2023;8(2):436-43. PMID 36775847
31: Lee WL, Low PS, Rajan U. Benign familial infantile epilepsy. J Pediatr 1993;123:588-90. PMID 8410514
32: Lee WL, Tay A, Ong HT, Goh LM, Monaco AP, Szepetowski P. Association of infantile convulsions with paroxysmal dyskinesias (ICCA syndrome): confirmation of linkage to human chromosome 16p12-q12 in a Chinese family. Hum Genet 1998;103:608-12. PMID 9860304
33: Lispi ML, Cusmai R, Vigevano F. Benign partial epilepsy in infancy: sporadic versus familial forms. Ann Neurol 2001;(Suppl 1):102.
34: Luovigsson P, Olafsson E, Rich SS, Johannesson G, Anderson VE. Benign infantile familial epilepsy: three families with multiple affected members in three generations. Epilepsia 1993;34(Suppl 2):18.
35: Marini C, Conti C, Mei D, et al. PRRT2 mutations in familial infantile seizures, paroxysmal dyskinesia, and hemiplegic migraine. Neurology 2012;79(21):2109-14. PMID 23077026
36: Millevert C, Weckhuysen S, ILAE Genetics Commission. ILAE Genetic Literacy Series: Self-limited familial epilepsy syndromes with onset in neonatal age and infancy. Epileptic Disord 2023;25(4):445-53. PMID 36939707
37: Ono S, Yoshiura K, Kinoshita A, et al. Mutations in PRRT2 responsible for paroxysmal kinesigenic dyskinesias also cause benign familial infantile convulsions. J Hum Genet 2012;57(5):338-41. PMID 22399141
38: Ramos-Lizana J, Martinez-Espinosa G, Rodriguez-Lucenilla MI, Aguirre-Rodriguez J, Aguilera Lopez P. Frequency, semiology and prognosis of benign infantile epilepsy. [Article in Spanish] Rev Neurol 2018;66(8):254-60. PMID 29645068
39: Saadeldin IY, Housawi Y, Al Nemri A, Al Hifzi I. Benign familial and non-familial infantile seizures (Fukuyama-Watanabe-Vigevano syndrome): a study of 14 cases from Saudi Arabia. Brain Dev 2010;32(5):378-84. PMID 19464832
40: Scheffer IE, Grinton BE, Heron SE, et al. PRRT2 phenotypic spectrum includes sporadic and fever-related infantile seizures. Neurology 2012;79(21):2104-8. PMID 23077018
41: Schubert J, Paravidino R, Becker F, et al. PRRT2 mutations are the major cause of benign familial infantile seizures. Hum Mutat 2012;33(10):1439-43. PMID 22623405
42: Specchio N, Terracciano A, Trivisano M, et al. PRRT2 is mutated in familial and non-familial benign infantile seizures. Eur J Paediatr Neurol 2013;17(1):77-81. PMID 22902423
43: Stelzl U, Worm U, Lalowski M, et al. A human protein-protein interaction network: a resource for annotating the proteome. Cell 2005;122(6):957-68. PMID 16169070
44: Striano P, Bordo L, Lispi ML, et al. A novel SCN2A mutation in family with benign familial infantile seizures. Epilepsia 2006a;47:218-20. PMID 16417554
45: Striano P, Lispi ML, Gennaro E, et al. Linkage analysis and disease models in benign familial infantile seizures: a study of 16 families. Epilepsia 2006b;47(6):1029-34. PMID 16822249
46: Sugiura M, Matsumoto A, Watanabe K, Negoro T, Takaesu E, Iwase K. Long-term prognosis of generalized convulsions in the first year of life, with special reference to benign infantile convulsions. Jpn J Epil Soc 1983;1:116-21.
47: Swoboda KJ, Soong B, McKenna C, et al. Paroxysmal kinesigenic dyskinesia and infantile convulsions: clinical and linkage studies. Neurology 2000;55(2):224-30. PMID 10908896
48: Szepetowski P, Rochette J, Berquin P, Piussan C, Lathrop GM, Monaco AP. Familial infantile convulsions and paroxysmal choreoathetosis: a new neurological syndrome linked to the pericentromeric region of human chromosome 16. Am J Hum Genet 1997;61:889-98.** PMID 9382100
49: Terwindt GM, Ophoff RA, Lindhout D, et al. Partial cosegregation of familial hemiplegic migraine and a benign familial infantile epileptic syndrome. Epilepsia 1997;38(8):915-21. PMID 9579893
50: Tian Y, Shi Z, Cai J, et al. Levetiracetam may be an unsuitable choice for patients with PRRT2-associated self-limited infantile epilepsy. BMC Pediatr 2023;23(1):529. PMID 37880614
51: Valente P, Castroflorio E, Rossi P, et al. PRRT2 Is a key component of the Ca(2+)-dependent neurotransmitter release machinery. Cell Rep 2016;15(1):117-31. PMID 27052163
52: Vanmolkot KR, Kors EE, Hottenga JJ, et al. Novel mutations in the Na+, K+-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann Neurol 2003;54(3):360-6. PMID 12953268
53: Vigevano F. Benign familial infantile seizures. Brain Dev 2005;27:172-7. PMID 15737697
54: Vigevano F, Di Capua M, Fusco L, Ricci S, Sebastianelli R, Lucchini P. Sixth-month benign familial convulsions. Epilepsia 1990;31:613. PMID 1418471
55: Vigevano F, Fusco L, Di Capua M, Ricci S, Sebastianelli R, Lucchini P. Benign infantile familial convulsions. Eur J Pediatr 1992;151:608-12.** PMID 1505581
56: Vigevano F, Sebastianelli R, Fusco L, et al. Benign infantile familial convulsions. In: Malafosse A, Genton P, Hirsch E, Marescaux C, Broglin D, Bernasconi R, editors. Idiopathic generalized epilepsies: clinical, experimental and genetic aspects. London: John Libbey, 1994:45-9.
57: Watanabe K, Negoro T, Aso K. Benign partial epilepsy with secondarily generalized seizures in infancy. Epilepsia 1993;34:635-8. PMID 8330573
58: Watanabe K, Yamamoto N, Negoro T, et al. Benign complex partial epilepsies in infancy. Pediatr Neurol 1987;3:208-11. PMID 3508067
59: Watanabe K, Yamamoto N, Negoro T, Takahashi I, Aso K, Maehara M. Benign infantile epilepsy with complex partial seizures. J Clin Neurophysiol 1990;7:409-16. PMID 2211995
60: Weber YG, Berger A, Bebek N, et al. Benign familial infantile convulsions: linkage to chromosome 16p12-q12 in 14 families. Epilepsia 2004;45:601-9. PMID 15144424
61: Yanagihara K, Sumida Y, Arai H, Imai K. Efficacy of low dose Carbamazepine therapy on the cluster of seizures in benign infantile convulsions. Epilepsia 2003;44(Suppl 8):118.
62: Zara F, Specchio N, Striano P, et al. Genetic testing in benign familial epilepsies of the first year of life: clinical and diagnostic significance. Epilepsia 2013;54(3):425-36.** PMID 23360469
63: Zuberi SM, Wirrell E, Yozawitz E, et al. ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia 2022;63(6):1349-97.** PMID 35503712

Contributors

All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.

Author

Parmpreet Dhillon MD

Dr. Dhillon of Montefiore Health System has no relevant financial relationships to disclose.
See Profile

Editor

Solomon L Moshé MD

Dr. Moshé of Albert Einstein College of Medicine has no relevant financial relationships to disclose.
See Profile

Former Authors

Mary C Spiciarich MD
Jerome Engel Jr MD PhD
Federico Vigevano MD, Filippo Sean Giorgi MD PhD, and Solomon L Moshe MD

Patient Profile

Age range of presentation: 3 to 20 months
Sex preponderance: male=female
Heredity: heredity typical

heredity may be a factor

autosomal dominant
Population groups selectively affected: none selectively affected
Occupation groups selectively affected: none selectively affected

ICD & OMIM codes

ICD-9: Convulsions in newborn: 779.0
ICD-10: Convulsions of newborn: P90
OMIM: Seizures, benign familial infantile, 1: #601764

Seizures, benign familial infantile, 2: #605751

Seizures, benign familial infantile, 3: #607745

Seizures, benign familial infantile, 4: #612627

Seizures, benign familial infantile, 5: #617080

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Self-limited (familial) infantile epilepsy

Associated Disorders

PRRT2 movement disorder

Differential Diagnosis

Dravet syndrome
electrolyte disturbance
epilepsy of infancy with migrating focal seizures
infection
intracranial injury
- malformations of cortical development
- metabolic disorder
- pyridoxine deficiency
- pyridoxine dependency
- self-limited (familial) neonatal-infantile epilepsy
- self-limited partial epilepsy with onset in infancy and early childhood with vertex spikes and waves during sleep on EEG
- viral infection

	• Dravet syndrome
	• Electrolyte disturbance
	• Epilepsy of infancy with migrating focal seizures
	• Infection
	• Intracranial injury
	• Malformations of cortical development
	• Metabolic disorder
	• Pyridoxine deficiency
	• Pyridoxine dependency
	• Self-limited (familial) neonatal-infantile epilepsy
	• Self-limited partial epilepsy with onset in infancy and early childhood with vertex spikes and waves during sleep on EEG
	• Viral infection

Self-limited (familial) infantile epilepsy …

Self-limited (familial) infantile epilepsy

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Differential diagnosis

Confusing conditions

Diagnostic workup

Management

Outcomes

References

Contributors

Author

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

NF2-related schwannomatosis

Photosensitive occipital lobe epilepsy

Breath-holding spells

Intermittent explosive disorder

Acute cerebellar ataxia in children

Headache in children: overview and treatment approaches

Alternating hemiplegia of childhood

Pyridoxine/P5P-dependent developmental epileptic encephalopathy

Self-limited (familial) infantile epilepsy

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Differential diagnosis

Confusing conditions

Diagnostic workup

Management

Outcomes

References

Contributors

Author

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

NF2-related schwannomatosis

Photosensitive occipital lobe epilepsy

Breath-holding spells

Intermittent explosive disorder

Acute cerebellar ataxia in children

Headache in children: overview and treatment approaches

Alternating hemiplegia of childhood

Pyridoxine/P5P-dependent developmental epileptic encephalopathy

This is an article preview.
Start a Free Account
to access the full version.